Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

NATH BIO-GENES (INDIA) LTD.

NSE : NATHBIOGENBSE : 537291ISIN CODE : INE448G01010Industry : AgricultureHouse : Private

BSE154.750 (0 %)

PREV CLOSE ( ) 154.75

OPEN PRICE ( ) 153.15

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 401

TODAY'S LOW / HIGH ( )151.10 154.75

52 WK LOW / HIGH ( )140.1 238

NSE152.23-1.07 (-0.7 %)

PREV CLOSE( ) 153.30

OPEN PRICE ( ) 152.56

BID PRICE (QTY) 152.22 (40)

OFFER PRICE (QTY) 152.23 (448)

VOLUME 1672

TODAY'S LOW / HIGH( ) 152.10 153.51

52 WK LOW / HIGH ( )137.55 238.69

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 13-09 2000

Management Info

- Chairman Satish Kagliwal - Managing Director

Registered Office

Address Nath House, Nath Road,P B No 318,,
Chhatrapati Sambhajinagar - (Aurangabad),
Maharashtra-431005

Phone 0240-2376314-7

Email info@nathseeds.com / investor@nathbiogenes.com

Website www.nathbiogenes.com

Registrars Details

Bigshare Services Pvt Ltd

Office No S6-2, 6th Floor, Pinnacle Business Park,Next to Ahura Centre, Mahakali Caves Road,Andheri (E),Mumbai

Listing : BSE, NSE

NEWS

14Nov Nath Bio-Genes (India) informs about p
Nath Bio-Genes (India) has attached presentation on Unaudited financial..

14Nov Nath Bio-Genes (India) informs about p
Nath Bio-Genes (India) has informed that it attached, presentation on Un..

24Apr Nath Bio-Genes (India) informs about c
Nath Bio-Genes (India) has informed that the Company will hold Earning C..

19Oct Nath Bio-Genes (India) submits analyst
Nath Bio-Genes (India) has informed that the Company will hold Earning C..

17Oct Nath Bio-Genes (India) informs about b
Nath Bio-Genes (India) has informed that the meeting of the Board of Dir..

Financials

Rs. in Millions

	QTR Sep 25	ANNUAL 25
Net Profit	42.02	421.4
Gross Profit	48.43	435.85
Operating Profit	91.22	570.21
Net Sales	397.71	3623.08

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Venkys India (BSE) 1443.00 (1.44%)	M.Cap ( in Cr)2028.44
Agri-Tech (India) (BSE) 148.70 (15.23%)	M.Cap ( in Cr)89.49
Naturite Agro Prod. (BSE) 263.50 (4.34%)	M.Cap ( in Cr)136.42
Transchem (BSE) 163.62 (5.00%)	M.Cap ( in Cr)200.27
Kaveri Seed (BSE) 973.70 (0.61%)	M.Cap ( in Cr)5008.37

Shareholding Pattern

	NON-INSTITUTION	53.32%
	PROMOTERS	45.6%
	MUTUAL FUNDS/UTI	0.76%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Aditya Birla SL Val...	0.14

Risk Disclosures on Derivatives

Smart Quotes

NATH BIO-GENES (INDIA) LTD.